Evan Wang
Stock Analyst at Guggenheim
(n/a)
# 4,679
Out of 4,829 analysts
4
Total ratings
n/a
Success rate
-91.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evan Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVAC CureVac | Reiterates: Neutral | n/a | $3.56 | - | 1 | Apr 5, 2024 | |
| IVVD Invivyd | Upgrades: Buy | $9 | $0.80 | +1,019.96% | 1 | Apr 5, 2024 | |
| VALN Valneva SE | Maintains: Buy | $18 → $17 | $6.55 | +159.54% | 1 | Mar 22, 2024 | |
| MRNA Moderna | Initiates: Neutral | n/a | $25.81 | - | 1 | Apr 26, 2023 |
CureVac
Apr 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.56
Upside: -
Invivyd
Apr 5, 2024
Upgrades: Buy
Price Target: $9
Current: $0.80
Upside: +1,019.96%
Valneva SE
Mar 22, 2024
Maintains: Buy
Price Target: $18 → $17
Current: $6.55
Upside: +159.54%
Moderna
Apr 26, 2023
Initiates: Neutral
Price Target: n/a
Current: $25.81
Upside: -